SCHEMBL7104988

SCHEMBL7104988

Cc1sc2ccccc2c1C1=C(c2c(C)sc3cc(C(=O)Cc4ccccc4)ccc23)C(F)(F)C(F)(F)C1(F)F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.37
▸ GRM1 Q13255 1/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ PLAU P00749 1/20 0.36
▸ PLA2G10 O15496 1/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ MAPT P10636 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ ALOX12 P18054 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.35
▸ SRD5A2 P31213 2/20 0.34
▸ HPGD P15428 1/20 0.34
▸ PTPN1 P18031 2/20 0.33
▸ BCL2 P10415 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7643452 0.87 PLA2G10 (0.39) CYP1A2RAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL6487227 0.85 PLA2G10 (0.39) CYP1A2RAB9ANPC1PLA2G10L3MBTL1
SCHEMBL5087788 0.81 SMN1; SMN2 (0.38) CYP1A2GRM1RAB9ANPC1SMN1; SMN2
SCHEMBL7648773 0.78 PLA2G10 (0.32) PLA2G10MAPTALDH1A1RXFP1KMT2A
SCHEMBL29492999 0.78 GPR3 (0.39) CYP1A2RAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL392860 0.78 GPR3 (0.39) CYP1A2RAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL6850965 0.78 MAOB (0.34) PLA2G10
SCHEMBL7645370 0.76 PLA2G10 (0.33) PLA2G10L3MBTL1
SCHEMBL6498933 0.74 PLA2G10 (0.37) RAB9ASMN1; SMN2PLA2G10MAPTALDH1A1
SCHEMBL6232782 0.72 LIMK1 (0.36) PTPN1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030118924-A1 Diarylethene derivatives and photochromic thin film prepared using the same KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY 2003-06-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030118924-A1 Diarylethene derivatives and photochromic thin film prepared using the same DIAPH1, CRY1, CRY2 CYP1A2 1012/4885GRM1 4538/4885RAB9A 705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback